HeartSciences Inc
HSCSBuild a strategy around HSCS
HeartSciences Inc AI Insights
Informational only. Not investment advice.Snapshot
- Cash burn of 7.5M TTM against 2.0M cash leaves ~3 months runway without financing[Free Cash Flow TTM]
- R&D spend of 3.7M TTM is 425x revenue (8.7K) - pre-commercial stage company[Research and Development TTM]
- Intangibles of 1.8M represent 44% of equity - IP valuation critical to thesis[Goodwill and Other Intangible Assets]
Watch Triggers
- Cash and Equivalents: Falls below 1.0M or financing announced — Sub-1M cash triggers going concern; financing terms reveal dilution severity
- Total Revenue TTM: Exceeds 100K quarterly — Any meaningful revenue signals commercial viability and extends runway thesis
- Accounts Receivable: Any positive balance — Zero AR suggests no sales pipeline; positive AR indicates customer adoption
Bull Case
Gross margin of 58% TTM indicates viable unit economics if commercialization succeeds; 657K inventory suggests product readiness
Debt/equity of 0.21 provides balance sheet flexibility for equity financing without covenant constraints
Bear Case
Revenue of 8.7K TTM with -5% 3Y growth signals failed commercialization; operating loss of 8.2M is 950x revenue
Cash runway under 3 months with no receivables pipeline; equity raise at distressed valuation or bankruptcy likely
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage HSCS's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Survival depends on near-term financing; dilution or failure highly probable within 6 months
- Cash of 2.0M vs monthly burn ~625K
- Zero accounts receivable suggests no commercial traction
- Current debt of 500K due near-term
Valuation Context
Caveats
Public Strategies Rankings
See how HeartSciences Inc ranks across different investment strategies.
Leverage HSCS's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
HSCS Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$6.4M | — | ||
$5.32M | — | ||
0.00 | — | ||
$8,669 | -41.0% | — | |
$-6.56 | — | ||
-95,044% | -44256.1% | — | |
-104,238% | -52370.0% | — | |
$-7.54M | — | ||
-221% | — | ||
Beta 5Y (Monthly) | unknown | — |
HSCS Dividend History
HSCS Stock Splits
HSCS SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
12/15/25 | 10/31/25 | 10-Q | |
09/11/25 | 07/31/25 | 10-Q | |
07/24/25 | 04/30/25 | Unknown | |
03/13/25 | 01/31/25 | 10-Q | |
12/16/24 | 10/31/24 | 10-Q | |
09/12/24 | 07/31/24 | 10-Q | |
07/29/24 | 04/30/24 | 10-K | |
03/14/24 | 01/31/24 | 10-Q | |
12/14/23 | 10/31/23 | 10-Q | |
09/14/23 | 07/31/23 | 10-Q | |
07/19/23 | 04/30/23 | 10-K | |
03/16/23 | 01/31/23 | 10-Q | |
12/15/22 | 10/31/22 | 10-Q | |
09/12/22 | 07/31/22 | 10-Q | |
07/29/22 | 04/30/22 | 10-K | |
06/17/22 | 01/31/22 | 424B4 | |
12/15/22 | 10/31/21 | 10-Q | |
09/12/22 | 07/31/21 | 10-Q | |
06/17/22 | 04/30/21 | 424B4 |